Yanni Hao
Chongqing Medical University
6 Papers
21 Citations
Yanni Hao is an academic researcher from Chongqing Medical University. The author has contributed to research in topics: Cancer & HEPACAM. The author has an hindex of 4, co-authored 5 publications.
Chat about Author
Papers
Negative regulation of tumor-infiltrating NK cell in clear cell renal cell carcinoma patients through the exosomal pathway
Yang Xia,Qiongfang Zhang,Quan Zhen,Yan Zhao,Nanjing Liu,Ting Li,Yanni Hao,Yao Zhang,Chunli Luo,Xiaohou Wu +9 more
TL;DR: The data indicate that exosomes from clear cell renal cell carcinoma induce natural killer cells dysfunction by regulating the TGF-β/SMAD pathway to evade innate immune surveillance.
75
Long noncoding RNA HOTAIR regulates the invasion and metastasis of prostate cancer by targeting hepaCAM
Ting Li,Nanjing Liu,Yingying Gao,Zhen Quan,Yanni Hao,Chaowen Yu,Luo Li,Mengjuan Yuan,Lingfang Niu,Chunli Luo,Xiaohou Wu +10 more
TL;DR: This study demonstrates that HOTAIR promotes invasion and metastasis of PCa by decreasing the inhibitory effect of hepaCAM on MAPK signalling, which may provide a new avenue towards therapeutic strategies and prognostic indicators for advanced prostate cancer.
32
HepaCAM inhibits the malignant behavior of castration-resistant prostate cancer cells by downregulating Notch signaling and PF-3084014 (a γ-secretase inhibitor) partly reverses the resistance of refractory prostate cancer to docetaxel and enzalutamide in vitro.
Zhongbo Du,Luo Li,Wei Sun,Xiao Wang,Yao Zhang,Zhixiong Chen,Mengjuan Yuan,Zhen Quan,Nanjing Liu,Yanni Hao,Ting Li,Jinhua Wang,Chunli Luo,Xiaohou Wu +13 more
TL;DR: This study indicates that HepaCAM potentially represents a therapeutic target and PF-3084014 may prove to a promising agent for use in the treatment of refractory PCa.
PLCε promotes urinary bladder cancer cells proliferation through STAT3/LDHA pathway‑mediated glycolysis.
TL;DR: It is demonstrated that PLCε may regulate glycolysis through the STAT3/LDHA pathway to take part in the development of human UBC.
PLCε promotes the Warburg effect and tumorigenesis through AKT/GSK3β/Cdc25a in bladder cancer.
TL;DR: In this paper , the effect of PLCε on the Warburg effect and tumorigenesis in bladder cancer (BCa) was explored, and it was shown that PLC was correlated with activation of protein kinase B (AKT) and cell division cycle 25 homolog A (Cdc25a) overexpression.
1